ezetimibe

ezetimibe

美 　英

• 网络依折麦布；依泽替米贝；依替米贝

例句

Merck and Schering did not begin such a trial until October 2005, three years after ezetimibe was approved.

在ezetimibe批准上市后三年，直到2005年10月，默克和先灵葆雅才开始这个试验。

The lack of data about ezetimibe highlights an aspect of the drug approval system that even sophisticated patients may not understand.

ezetimibe数据资料的不足暴露了药品审批制度的一个方面，即使是精明的病人可能都弄不明白。

For the interim doctors and patients are left with a quandary as to the efficacy and safety of ezetimibe.

因此目前对于医生和患者来说，依析替林的有效性和安全性依然是个问题。

and the compound VII is reduced to a compound IX ezetimibe by a borane chiral reducing agent.

化合物VII经硼烷类手性还原剂还原为化合物IX依泽替米贝。

In this article, the mechanism, pharmacokinetics and advances in clinical application of ezetimibe are summarized.

本文综述了依折麦布的作用机制、药动学特性及其在临床应用中的最新进展。

With little long-term data about ezetimibe's risks, scientists are scrambling to find an explanation for the seeming cancer link.

几乎没有关于ezetimibe风险的长期资料，科学家们正在争先恐后的找寻它和癌症有关系的缘由。

Still, the concerns about ezetimibe's potential risks and lack of effectiveness have discouraged some patients from using the medicine.

然而，对ezetimibe潜在危险性和效力不足的担忧还是影响了病人使用该药。

So ezetimibe remains heavily prescribed despite questions about both its effectiveness and whether it is linked to cancer.

所以尽管有对Ezetimibe有效性和是否致癌的疑问，但是它依旧有很多的处方量。

Dr. Jacks said Merck and Schering could not easily resolve the questions about ezetimibe's potential risks.

Jacks博士说，默克和先灵葆雅不太可能轻而易举解决ezetimibe潜在风险性的问题。

But other scientists say they have a plausible explanation for why ezetimibe may cause cancer.

但是其他一些科学家说他们对为什么ezetimibe会引起癌症有一个看似合理的解释。

Ezetimibe and cancer: what is the risk?

依析替林和癌症：谁更危险？

The New Cholesterol Absorption Inhibitor Ezetimibe and Its Clinical Advances on Combination with Statins

新型胆固醇吸收抑制剂依泽替米贝与他汀类联合应用评价

The Selective Cholesterol Absorption Inhibitor-Ezetimibe

胆固醇吸收抑制剂——依折麦布

Ezetimibe, a new cholesterol absorption inhibitor

新型胆固醇吸收抑制剂依泽替米贝